|
JP4521738B2
(ja)
*
|
1999-03-30 |
2010-08-11 |
住友化学株式会社 |
ベンゾチアゾール化合物、その製造法、液晶組成物及び液晶素子
|
|
US7056917B2
(en)
|
2001-04-26 |
2006-06-06 |
Daiichi Pharmaceutical Co., Ltd. |
Drug efflux pump inhibitor
|
|
JP4303109B2
(ja)
*
|
2001-10-04 |
2009-07-29 |
メルク エンド カムパニー インコーポレーテッド |
代謝共役型グルタミン酸受容体−５のヘテロアリール置換テトラゾール調節剤
|
|
WO2004007469A1
(en)
*
|
2002-07-12 |
2004-01-22 |
Warner-Lambert Company Llc |
New alkynylated quinazolin compounds as mmp-13 inhibitors
|
|
EP1434585A1
(en)
*
|
2001-10-12 |
2004-07-07 |
Warner-Lambert Company LLC |
Alkyne matrix metalloproteinase inhibitors
|
|
WO2003033477A1
(en)
*
|
2001-10-12 |
2003-04-24 |
Warner-Lambert Company Llc |
Alkynlated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitor
|
|
WO2003033478A1
(en)
*
|
2001-10-12 |
2003-04-24 |
Warner-Lambert Company Llc |
Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors
|
|
US6962922B2
(en)
|
2001-10-12 |
2005-11-08 |
Warner-Lambert Company Llc |
Alkynylated quinazoline compounds
|
|
US6747147B2
(en)
|
2002-03-08 |
2004-06-08 |
Warner-Lambert Company |
Oxo-azabicyclic compounds
|
|
US6894057B2
(en)
|
2002-03-08 |
2005-05-17 |
Warner-Lambert Company |
Oxo-azabicyclic compounds
|
|
AU2003221969A1
(en)
|
2002-04-19 |
2003-11-03 |
3M Innovative Properties Company |
Materials for organic electronic devices
|
|
PA8578101A1
(es)
*
|
2002-08-13 |
2004-05-07 |
Warner Lambert Co |
Derivados de heterobiarilo como inhibidores de metaloproteinasa de la matriz
|
|
US7452911B2
(en)
|
2002-10-31 |
2008-11-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
|
|
DE10250708A1
(de)
*
|
2002-10-31 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
|
AU2003278600A1
(en)
*
|
2002-11-01 |
2004-05-25 |
Takeda Pharmaceutical Company Limited |
Agent for preventing or treating neuropathy
|
|
US7192657B2
(en)
|
2003-04-15 |
2007-03-20 |
3M Innovative Properties Company |
Ethynyl containing electron transport dyes and compositions
|
|
US7271406B2
(en)
|
2003-04-15 |
2007-09-18 |
3M Innovative Properties Company |
Electron transport agents for organic electronic devices
|
|
WO2005100331A2
(en)
*
|
2004-04-14 |
2005-10-27 |
Ranbaxy Laboratories Limited |
Antidiabetic agents
|
|
WO2008074835A1
(en)
*
|
2006-12-20 |
2008-06-26 |
Novartis Ag |
2-substituted 5-membered heterocycles as scd inhibitors
|
|
EP2502919A4
(en)
*
|
2009-11-17 |
2013-06-26 |
Mitsubishi Tanabe Pharma Corp |
PREPARATION FOR A BIPHENYL DERIVATIVE
|
|
IN2015DN02241A
(https=)
*
|
2012-09-26 |
2015-08-21 |
Api Corp |
|
|
EP3066096A1
(de)
|
2013-11-08 |
2016-09-14 |
Bayer Pharma Aktiengesellschaft |
Substituierte uracile als chymase inhibitoren
|
|
GEAP201814220A
(en)
|
2013-12-24 |
2018-03-12 |
Oncotartis Inc |
Benzamide and nicotinamide compounds and methods of using same
|
|
CN106146391A
(zh)
*
|
2015-04-15 |
2016-11-23 |
中国科学院上海药物研究所 |
5-芳香炔基取代的苯甲酰胺类化合物及其制备方法、药物组合物和用途
|
|
KR102482673B1
(ko)
|
2016-07-05 |
2022-12-30 |
광저우 맥시노벨 파마수티컬스 씨오., 엘티디. |
방향족 아세틸렌 또는 방향족 에틸렌계 화합물, 그의 중간체, 제조 방법, 약물 조성물 및 용도
|
|
CN109988144B
(zh)
|
2017-12-29 |
2024-07-05 |
广州再极医药科技有限公司 |
芳香乙烯或芳香乙基类衍生物、其制备方法、中间体、药物组合物及应用
|